Normal Values of Brain Natriuretic Peptide in Healthy Newborn
1 other identifier
observational
167
0 countries
N/A
Brief Summary
Brain natriuretic peptide (BNP) is an important tool for diagnosis, risk stratification and prognosis in pediatric patients with heart failure1. In newborn, after delivery, the BNP plays an important role in cardiopulmonary hemodynamics by stimulating vasodilatation and diuresis. The gradual decrease in pulmonary pressure and the initiation of diuresis as expression of renal maturity could explain the subsequent decrease in serum values. This would suggest that, in healthy newborns, BNP values should be found within a given ranges. However, the evidence suggests an important variability in BNP values 2 - 4. In the other hand, in the newborn with respiratory distress BNP could have a high negative predictive value to rule out acute myocardial processes, as responsible for clinical deterioration, from infectious, metabolic or respiratory processes; with a potential of improvement in medical care. Even the increased use of this biomarker in clinical practice, until our knowledge, BNP normal values remain unknown in the healthy newborn. Therefore, the investigators performed a pioneer study to establish normal values in healthy newborn population. Multi-center, prospective and observational study was carried out. Objective: To establish normal BNP values in healthy newborn.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2014
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2015
CompletedFirst Submitted
Initial submission to the registry
October 7, 2015
CompletedFirst Posted
Study publicly available on registry
October 14, 2015
CompletedOctober 19, 2018
October 1, 2018
1 year
October 7, 2015
October 18, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
BNP values
within the first minute after birth and data will present through study completion
Study Arms (2)
Healthy newborn
Healthy newborn at term of healthy mother.
Preeclamptic newborn
Newborn at term of mother with pre-eclampsia with severity features.
Interventions
Blood sample of umbilical artery from umbilical cord immediately after birth.
Eligibility Criteria
Healthy term newborn obtained by vaginal delivery and/or cesarean section.
You may qualify if:
- healthy mother with pregnancy at term (38 to 42 gestational weeks) with adequate prenatal care.
- newborns with Apgar score ≥ 7 at 0 and 5 minutes respectively.
You may not qualify if:
- newborns of mothers with pregnancy-associated diseases.
- newborns with chromosomopathies detected during the antenatal care and newborns with signs of cardiac and/or respiratory compromise.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (1)
Rodriguez D, Garcia-Rivas G, Laresgoiti-Servitje E, Yanez J, Torre-Amione G, Jerjes-Sanchez C. B-type natriuretic peptide reference interval of newborns from healthy and pre-eclamptic women: a prospective, multicentre, cross-sectional study. BMJ Open. 2018 Oct 17;8(10):e022562. doi: 10.1136/bmjopen-2018-022562.
PMID: 30337314DERIVED
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 7, 2015
First Posted
October 14, 2015
Study Start
April 1, 2014
Primary Completion
April 1, 2015
Study Completion
April 1, 2015
Last Updated
October 19, 2018
Record last verified: 2018-10